Compare Kuwer Industries with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.85%
- Poor long term growth as Net Sales has grown by an annual rate of 0.26% and Operating profit at 19.43% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.24 times
Flat results in Dec 25
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 8 Cr (Micro Cap)
91.00
13
0.00%
2.02
0.50%
0.46
Total Returns (Price + Dividend) 
Kuwer Industries for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Kuwer Industries Ltd Stock Falls to 52-Week Low of Rs.7.38
Kuwer Industries Ltd, a player in the Commodity Chemicals sector, has touched a fresh 52-week low of Rs.7.38 today, marking a significant decline in its stock price amid ongoing underperformance relative to its sector and broader market indices.
Read full news article
Kuwer Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend
Kuwer Industries Ltd, a player in the commodity chemicals sector, has recorded a fresh 52-week low of Rs.7.76 today, marking a significant decline amid a sustained downward trajectory over the past week. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics.
Read full news article
Kuwer Industries Ltd Stock Hits 52-Week Low at Rs.7.99
Kuwer Industries Ltd, a player in the Commodity Chemicals sector, touched a new 52-week low of Rs.7.99 today, marking a significant decline in its stock price amid subdued financial performance and challenging market conditions.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Feb-2026 | Source : BSENewspaper Publications in which the Un-audited Standalone Financial Results of the Company for the Quarter and Nine Months ended on 31.12.2025 have been published.
Unaudited Financial Results As On 31.12.2025
14-Feb-2026 | Source : BSEThe Board of Directors in their meeting held on 14.02.2026 has inter alia considered and approved unaudited Standalone Financial results for the Quarter and nine months ended on 31.12.2025
Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 14.02.2026
14-Feb-2026 | Source : BSEThe Board of Director in their meeting held on 14.02.2026 has inter alia considered and approved the Unaudited Standalone Financial Results of the Company for the Quarter and Nine Months ended on 31.12.2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Tarun Aggarwal (27.26%)
Smita Singh (3.05%)
47.55%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -13.03% vs 10.73% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -94.67% vs 204.97% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 1.47% vs -7.50% in Sep 2024
Growth in half year ended Sep 2025 is 600.00% vs 100.43% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.39% vs -3.13% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -69.81% vs 133.54% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -1.77% vs -12.01% in Mar 2024
YoY Growth in year ended Mar 2025 is 318.18% vs -54.17% in Mar 2024






